---
title: "The Branded Health Service Medicines (Costs) (Amendment) Regulations 2026"
id: ad3cc2df-b3f9-4a9c-9156-65b6f0cd6c30
authority: uk
place: "United Kingdom"
applies_also_from: []
kind: regulation
in_force: true
publisher_url: https://www.legislation.gov.uk/uksi/2026/614
attribution: "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
solon_url: https://solon.orangecat.ch/law/ad3cc2df-b3f9-4a9c-9156-65b6f0cd6c30
language: en
in_force_from: 2026-07-01
date_basis: publisher
status: consolidated
source_url: https://www.legislation.gov.uk/uksi/2026/614/data.xml
read_on: 2026-11-10
sha256: 9d5ba692bd77c854d5a9fd0576c89281588883589c7e2fefb9279ab8e0826d80
provisions: 3
---

# The Branded Health Service Medicines (Costs) (Amendment) Regulations 2026

## Title and introductory text {#prelims}

2026 No. 614
NATIONAL HEALTH SERVICE, ENGLAND AND WALES
NATIONAL HEALTH SERVICE, SCOTLAND
HEALTH AND PERSONAL SOCIAL SERVICES, NORTHERN IRELAND
The Branded Health Service Medicines (Costs) (Amendment) Regulations 2026
Made
9th June 2026
Laid before Parliament
10th June 2026
Coming into force
1st July 2026
The Secretary of State for Health and Social Care makes the following Regulations in exercise of the powers conferred by sections 263(1)(b) and (c), (2) and (5), 264(3), 266(1) and 272(7)(a) and (b) and (8) of the National Health Service Act 2006 having had regard to the matters specified in section 266(3), (4) and (4A) of that Act.
The Secretary of State has consulted in accordance with sections 263(1) and (1A) of that Act.

## 1 Citation, commencement and extent {#regulation-1}

(1) These Regulations may be cited as the Branded Health Service Medicines (Costs) (Amendment) Regulations 2026 and come into force on 1st July 2026.
(2) These Regulations extend to England and Wales, Scotland and Northern Ireland.

## 2 Amendments to the Branded Health Service Medicines (Costs) Regulations 2018 {#regulation-2}

(1) Regulation 3 (payment scheme) of the Branded Health Service Medicines (Costs) Regulations 2018 is amended as follows.
(2) In paragraph (1), for the table substitute the following table—
Table
Applicable Period | Newer presentation payment percentage | Older presentation payment percentage
1st July 2026 to the end of 2026 | 16.5% | 11%
1st January 2027 to the end of 2027 and any subsequent calendar year | 16.5% | 10.9%
.
(3) In paragraph (1AB)—
(a) for “1st July 2025 and ending at the end of 2025”, substitute “1st July 2026 and ending at the end of 2026”; and
(b) for “31.3% and not 23.4%”, substitute “8.7% and not 16.5%”.
(4) In paragraph (1AC)—
(a) for “1st July 2025 and ending at the end of 2025”, substitute “1st July 2026 and ending at the end of 2026”;
(b) in sub-paragraph (a), for “1st January 2025 and ending at the end of 30 June 2025”, substitute “1st January 2026 and ending at the end of 30 June 2026”; and
(c) in sub-paragraph (b), for “15.5%”, substitute “24.3%”.